Davos

Lunit Joins World Economic Forum Global Innovators Community

Retrieved on: 
Wednesday, October 26, 2022

The World Economic Forum provides the Global Innovators Community with a platform to engage with public- and private-sector leaders and to contribute new solutions to overcome current crises and build future resiliency.

Key Points: 
  • The World Economic Forum provides the Global Innovators Community with a platform to engage with public- and private-sector leaders and to contribute new solutions to overcome current crises and build future resiliency.
  • As part of the Global Innovators Community, Lunit will engage with the Forum's Platforms to help define the global agenda on key issues.
  • "We're pleased to welcome Lunit to the Global Innovators Community and we're looking forward to leveraging their insights to inform our content work on the Forum's Platform for Shaping the Future of Health and Healthcare," said Verena Kuhn, Global Innovators Community Head, World Economic Forum.
  • Following its invitation to join the Global Innovators, CEO Brandon Suh of Lunit will be present at the upcoming World Economic Forum Annual Meeting in January, at Davos.

C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments

Retrieved on: 
Friday, October 21, 2022

The company boldly launched the PrecivityAD blood test during the height of the COVID pandemic in October 2020.

Key Points: 
  • The company boldly launched the PrecivityAD blood test during the height of the COVID pandemic in October 2020.
  • Molecular Neurodegeneration was the first to distribute a research paper that stated the PrecivityAD blood test can accurately identify brain amyloid status based on a single blood sample.
  • AARP The Magazine reported on Shelby Hileman, who also received an Alzheimers diagnosis after her doctor reviewed her PrecivityAD blood test result.
  • In a TV story , a wife shared why her husband decided to take the PrecivityAD blood test after his doctor recommended it.

Tatum Receives $41.5 Million Funding to Accelerate Growth of Unique Blockchain Development Platform, Speeding Time to Market for Digital Finance and Web 3.0 Applications

Retrieved on: 
Wednesday, October 12, 2022

LONDON and MIAMI, Oct. 12, 2022 /PRNewswire/ -- Tatum, the company drastically simplifying blockchain applications development, today announced it has received $41.5 million in funding to accelerate marketing, educational efforts and community building for slashing the complexity and time-to-market of creating blockchain-based applications critical to digital finance and Web 3.0. The investment augments the company's previous financing, and includes Evolution Equity Partners as lead, as well as Octopus Ventures, 3VC, Tensor Ventures, Depo Ventures, Leadblock Fund, Circle, and founders of Bitpanda.

Key Points: 
  • "Blockchain has proven essential to the explosive growth and broad innovation of digital finance and Web 3.0," said Jiri Kobelka, co-founder and chief executive officer, Tatum.
  • "Tatum is the first company to squarely address the complexities, necessary technological expertise and lengthy development times that blockchain applications require.
  • We have revolutionized blockchain application creation by slashing development times from months or years of engineering time down to just days."
  • Tatum provides the world's first blockchain development platform to speed the creation of blockchain applications and enable greater functionality and higher quality.

Cure® Names Seema Kumar Chief Executive Officer

Retrieved on: 
Wednesday, October 5, 2022

NEW YORK, Oct. 5, 2022 /PRNewswire/ --Cure, a healthcare innovation campus in New York City, announced today that Seema Kumar has been named Chief Executive Officer (CEO).

Key Points: 
  • NEW YORK, Oct. 5, 2022 /PRNewswire/ --Cure, a healthcare innovation campus in New York City, announced today that Seema Kumar has been named Chief Executive Officer (CEO).
  • Ms. Kumar joins Cure today from Johnson & Johnson where she spent nearly 20 years in senior leadership positions, most recently serving as Global Head of the Office of Innovation, Global Health and Scientific Engagement.
  • Prior to that she was Chief of Staff and Chief Communications Officer at MIT's Whitehead Institute, playing a leading role in the Human Genome Project and the creation and launch of the Broad Institute.
  • "I am thrilled and excited to be joining Cure as its CEO and lead the mission to help transform and advance healthcare by continuing to build an active healthcare network and diverse community," said Seema Kumar, Chief Executive Officer of Cure.

CasperLabs to Address the Blockchain Scalability Challenge at Blockchain Expo North America

Retrieved on: 
Thursday, September 29, 2022

Blockchain Expo North America is a technology conference and exhibition, with thought-leading discussions and top-level content, covering all recent developments in the Blockchain ecosystem.

Key Points: 
  • Blockchain Expo North America is a technology conference and exhibition, with thought-leading discussions and top-level content, covering all recent developments in the Blockchain ecosystem.
  • A key obstacle to blockchain adoption surrounds scalability and I look forward to discussing those challenges as well as the solutions that will accelerate widespread blockchain use into the future.
  • As CasperLabs CTO, Medha is on a mission to make blockchain the platform for doing business in the future.
  • CasperLabs, a leading blockchain software company for the enterprise market, is re-imagining blockchain for enterprise with a future proof solution.

DAVOS ALZHEIMERS COLLABORATIVE FEATURED ON THE TODAY SHOW DURING WORLD ALZHEIMER’S AND HISPANIC HERITAGE MONTH

Retrieved on: 
Tuesday, September 27, 2022

For too long, Alzheimers research has excluded populations most in need of support, said George Vradenburg, Founding Chairman of the Board, Davos Alzheimers Collaborative.

Key Points: 
  • For too long, Alzheimers research has excluded populations most in need of support, said George Vradenburg, Founding Chairman of the Board, Davos Alzheimers Collaborative.
  • DACs Rio Grande research program will bring generations of families into this study, uniting communities to end Alzheimers.
  • The segment was reported by NBC and MSNBC Weekend Anchor, bestselling author, and filmmaker, Richard Lui, who is also a longtime Alzheimers advocate with personal experience caregiving for his father with Alzheimers.
  • The study is led by Dr. Rhoda Au, Director of the Global Cohort Development Program of the Davos Alzheimers Collaborative, which aims to build a cohort of one million diverse people.

ONWARD Announces Appointment of Vivian Riefberg to Board of Directors

Retrieved on: 
Monday, September 26, 2022

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.

Key Points: 
  • ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
  • Her appointment to the Board will be presented for shareholder approval at the next Annual General Meeting.
  • View the full release here: https://www.businesswire.com/news/home/20220926005494/en/
    Vivian Riefberg joins the ONWARD Medical Board of Directors (Photo: Business Wire)
    Vivian Riefberg is a distinguished expert in health care, government, and strategy.
  • ONWARD has the opportunity to build a very special enterprise that is both successful and impactful, said Vivian Riefberg.

C₂N Diagnostics Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health

Retrieved on: 
Wednesday, September 21, 2022

C2N Diagnostics , a leader in advanced brain health diagnostics, today announced it has entered a partnership with Grupo Fleury (BVMF: FLRY), one of Brazils leading healthcare companies, to bring blood-based tests that aid in early Alzheimers diagnosis to patient care in Brazil.

Key Points: 
  • C2N Diagnostics , a leader in advanced brain health diagnostics, today announced it has entered a partnership with Grupo Fleury (BVMF: FLRY), one of Brazils leading healthcare companies, to bring blood-based tests that aid in early Alzheimers diagnosis to patient care in Brazil.
  • Data from the Brazilian Ministry of Health estimate that there are 1.2 million cases of Alzheimer's disease in Brazil, most of them without an established diagnosis.
  • Grupo Fleury is a premier organization with an established history of providing high-quality healthcare services to patients throughout Brazil, including diagnostic and precision medicine.
  • C2N Diagnostics is a leader in advanced brain health diagnostics with a vision to bring Clarity Through Innovation.

sparks & honey Expands Advisory Board, Welcomes New Experts in Emerging Tastes & Equitable Futures

Retrieved on: 
Tuesday, September 20, 2022

As an organization that hinges on constant learning and open thinking, we are always seeking future-forward leaders that share our ideals and push the boundaries to add to our Advisory Board, said Terry Young, Founder & CEO of sparks & honey.

Key Points: 
  • As an organization that hinges on constant learning and open thinking, we are always seeking future-forward leaders that share our ideals and push the boundaries to add to our Advisory Board, said Terry Young, Founder & CEO of sparks & honey.
  • Were very much looking forward to learning from and working with these remarkable women.
  • sparks & honey is a cultural intelligence consultancy helping organizations understand and take advantage of explosive cultural shifts, as well as cultural movements that develop over time.
  • The consultancy produces cultural intelligence reports which investigate emerging shifts in culture on topics ranging from Gen Z to societal Uncertainty .

Greenlabs Joins World Economic Forum, Standing Tall as Global Innovator

Retrieved on: 
Thursday, September 15, 2022

Joined WEF September 1st as a Global Innovator, will attend Annual Meeting at Davos next year

Key Points: 
  • Joined WEF September 1st as a Global Innovator, will attend Annual Meeting at Davos next year
    SEOUL, South Korea, Sept. 15, 2022 /PRNewswire/ --Greenlabs, a trailblazer in the data-based agrifood industry, joined the World Economic Forum (WEF) as a Global Innovator on the 1st of this month.
  • Recognized as a Global Innovator, the company is inivited to join the Annual Meeting at Davos in Switzerland, hosted by the World Economci Forum, in January next year.
  • In addition to participating in the Annual Meeting at Davos, Greenlabs is expanding its agrifood innovation on the world stage.
  • Verena Kuhn, Head of Global Innovator community at the World Economic Forum, commented, "We are very pleased to have Greenlabs as a Global Innovator.